Hansoh Pharmaceutical Group (HKG:3692) reported 4.26 billion yuan in profit attributable to owners for the first half, compared with 3.13 billion yuan a year ago, a Wednesday bourse filing showed.
EPS moved to 0.70 yuan from 0.53 yuan year over year.
For the six months ended June 30, revenue was 8.3 billion yuan, versus 7.43 billion yuan previously, the pharmaceutical company said.
The company declared an interim dividend of HK$0.285 per share for the period, payable Oct. 29 to shareholders of record as of Sept. 25.